๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of relapsing polychondritis in the era of biological agents

โœ Scribed by Eoghan M. McCarthy; Gaye Cunnane


Publisher
Springer
Year
2009
Tongue
English
Weight
131 KB
Volume
30
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A new role for magnetic resonance imagin
โœ Yolanda D. Heman-Ackah; Kent B. Remley; George S. Goding Jr ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB ๐Ÿ‘ 2 views

Background. Relapsing polychondritis involving the upper airway is a rare cause of airflow obstruction and hoarseness. The diagnosis of relapsing polychondritis depends on clinical signs, characteristic findings on cartilage biopsy, and response to treatment. Delays in diagnosis and treatment can in

Positioning biologic agents in the treat
โœ Stephen B. Hanauer ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB

One decade after the emergence of biologic therapy for Crohn's disease (CD), our treatment algorithms are beginning to change. Once reserved for patients with refractory disease, disease unresponsive to conventional therapies, or those requiring multiple courses of corticosteroids, there is increasi

Apheresis in the treatment of chronic re
โœ Harry Handelsman ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 309 KB

As a distinct inflammatory demyelinating disease, chronic relapsing polyneuropathy can be extremely debilitating and cause respiratory failure leading to death. The cause of the disorder is unknown, although evidence suggests that immune dysfunction plays some role in its pathogenesis.